Show simple item record

dc.contributor.authorAntonia, S
dc.contributor.authorVillegas, A
dc.contributor.authorDaniel, D
dc.contributor.authorVicente, D
dc.contributor.authorMurakami, S
dc.contributor.authorHui, R
dc.contributor.authorKurata, T
dc.contributor.authorChiappori, A
dc.contributor.authorLee, KH
dc.contributor.authorde Wit, M
dc.contributor.authorCho, BC
dc.contributor.authorBourhaba, M
dc.contributor.authorQuantin, X
dc.contributor.authorTokito, T
dc.contributor.authorMekhail, T
dc.contributor.authorPlanchard, D
dc.contributor.authorKim, Y
dc.contributor.authorKarapetis, C
dc.contributor.authorHiret, S
dc.contributor.authorOstoros, G
dc.contributor.authorKubota, K
dc.contributor.authorGray, J
dc.contributor.authorPaz-Ares, L
dc.contributor.authorDe Carpeno, JDC
dc.contributor.authorFaivre-Finn, Corinne
dc.contributor.authorReck, M
dc.contributor.authorVansteenkiste, J
dc.contributor.authorSpigel, D
dc.contributor.authorWadsworth, C
dc.contributor.authorTaboada, M
dc.contributor.authorDennis, P
dc.contributor.authorOzguroglu, M
dc.date.accessioned2019-02-08T15:20:06Z
dc.date.available2019-02-08T15:20:06Z
dc.date.issued2018en
dc.identifier.citationAntonia S, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, et al. PL02.01 Overall survival with durvalumab versus placebo after chemoradiotherapy in stage III NSCLC: updated results from PACIFIC. J Thorac Oncol. 2018;13(10):S184.en
dc.identifier.doi10.1016/j.jtho.2018.08.010en
dc.identifier.urihttp://hdl.handle.net/10541/621507
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.jtho.2018.08.010en
dc.titleOverall survival with durvalumab versus placebo after chemoradiotherapy in stage III NSCLC: updated results from PACIFICen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentH. Lee Moffitt Cancer Center and Research Institute, Tampa, FL/USen
dc.identifier.journalJournal of Thoracic Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record